According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -โน169.69. In 2023 the company made an earnings per share (EPS) of -โน293.09 an increase over its 2022 EPS that were of -โน515.91.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -โน165.10 | -43.67% |
2023 | -โน293.09 | -43.19% |
2022 | -โน515.91 | 2.21% |
2021 | -โน504.77 | -51.72% |
2020 | -โน1,046 | -49.17% |
2019 | -โน2,057 | -43.93% |
2018 | -โน3,668 | -29.61% |
2017 | -โน5,211 | 82.33% |
2016 | -โน2,858 | 40.54% |
2015 | -โน2,034 |